Nifty

:

24450.45

Sensex

:

78918.90

-315.45 (-1.27%)
-1097.00 (-1.37%)

Login

Nifty
Sensex

:
:

24450.45
78918.90

-315.45 (-1.27%)
-1097.00 (-1.37%)

SMS Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

Rating :

69/99

BSE: 532815 | NSE: SMSPHARMA

Watchlist

NSE BSE

375.75

06-Mar-2026

Open
High
Low
Previous Close

386.05
388
374.05
386.05

Volume
Traded Value (lacs)
52 Week High
52 Week Low

148488
56718982.45
403
186.62

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,518.51
39.27
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,743.13
0.11%
4.68

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

2.50
6.81
14.46

EBITDA CAGR (%)

10 Years
5 Years
3 Years

4.53
2.79
20.58

PAT CAGR (%)

10 Years
5 Years
3 Years

4.93
2.03
158.99

P:E (Median)

8 Years
5 Years
3 Years

19.80
28.96
34.46

P:BV (Average)

8 Years
5 Years
3 Years

2.42
2.82
3.19

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.70
15.70
18.03

Earnings Forecasts:

(Updated: 28-02-2026)

Description 2024 2025 2026 2027
Adj EPS 7.8
P/E Ratio 48.17
Revenue 782.75
EBITDA 138.99
Net Income 69.14
ROA 6.32
P/B Ratio 4.97
ROE 11.76
FCFF -58.86
FCFF Yield -1.53
Net Debt 269.17
BVPS 75.56

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 210.45 173.35 21.40% 242.43 196.75 23.22% 196.05 164.45 19.22% 248.20 245.80 0.98%
Expenses 166.65 140.05 18.99% 194.05 164.89 17.68% 157.19 130.99 20.00% 206.85 212.31 -2.57%
EBITDA 43.79 33.30 31.50% 48.38 31.86 51.85% 38.86 33.47 16.10% 41.35 33.49 23.47%
EBIDTM 20.81% 19.21% 19.96% 16.19% 19.82% 20.35% 16.66% 13.62%
Other Income 3.75 2.13 76.06% 1.43 1.31 9.16% 0.59 1.37 -56.93% 1.42 1.65 -13.94%
Interest 6.22 4.20 48.10% 5.74 4.61 24.51% 5.84 4.67 25.05% 5.06 5.61 -9.80%
Depreciation 10.02 8.70 15.17% 10.02 8.62 16.24% 9.75 8.38 16.35% 8.64 7.92 9.09%
PBT 31.31 22.53 38.97% 34.06 19.94 70.81% 23.86 21.78 9.55% 29.06 21.61 34.47%
Tax 7.97 5.36 48.69% 8.91 5.68 56.87% 5.65 5.46 3.48% 8.44 5.69 48.33%
PAT 23.34 17.17 35.93% 25.14 14.26 76.30% 18.21 16.33 11.51% 20.62 15.92 29.52%
PATM 11.09% 9.91% 10.37% 7.25% 9.29% 9.93% 8.31% 6.48%
EPS 2.49 1.83 36.07% 2.68 1.52 76.32% 1.94 1.74 11.49% 2.20 1.70 29.41%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 210.45 173.35 21.40% 242.43 196.75 23.22% 196.05 164.45 19.22% 248.20 245.80 0.98%
Expenses 166.80 140.14 19.02% 194.06 165.28 17.41% 156.68 130.94 19.66% 207.39 212.18 -2.26%
EBITDA 43.64 33.21 31.41% 48.37 31.47 53.70% 39.37 33.51 17.49% 40.81 33.62 21.39%
EBIDTM 20.74% 19.16% 19.95% 15.99% 20.08% 20.38% 16.44% 13.68%
Other Income 3.75 2.13 76.06% 1.43 1.31 9.16% 0.59 1.37 -56.93% 1.42 1.65 -13.94%
Interest 6.22 4.20 48.10% 5.74 4.61 24.51% 5.84 4.67 25.05% 5.06 5.61 -9.80%
Depreciation 10.02 8.70 15.17% 10.02 8.62 16.24% 9.75 8.38 16.35% 8.64 7.92 9.09%
PBT 31.16 22.44 38.86% 34.04 19.54 74.21% 24.37 21.83 11.64% 28.52 21.74 31.19%
Tax 7.97 5.36 48.69% 8.91 5.68 56.87% 5.65 5.46 3.48% 8.44 5.69 48.33%
PAT 23.19 17.08 35.77% 25.13 13.86 81.31% 18.71 16.37 14.29% 20.08 16.05 25.11%
PATM 11.02% 9.85% 10.37% 7.05% 9.55% 9.96% 8.09% 6.53%
EPS 2.51 2.15 16.74% 2.70 1.67 61.68% 2.31 1.95 18.46% 2.29 2.04 12.25%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 897.13 782.75 709.26 522.05 519.87 563.18 411.95 464.91 464.93 445.49 611.53 Net Sales Growth 14.97% 10.36% 35.86% 0.42% -7.69% 36.71% -11.39% 0.00% 4.36% -27.15% Cost Of Goods Sold 512.54 436.09 424.04 335.60 275.30 340.00 246.36 292.71 289.90 295.85 385.15 Gross Profit 384.59 346.66 285.22 186.44 244.58 223.18 165.59 172.20 175.03 149.64 226.38 GP Margin 42.87% 44.29% 40.21% 35.71% 47.05% 39.63% 40.20% 37.04% 37.65% 33.59% 37.02% Total Expenditure 724.74 642.77 592.28 467.32 405.10 442.04 331.92 374.77 371.59 370.35 522.32 Power & Fuel Cost - 56.76 47.12 35.97 32.58 23.31 18.99 21.75 22.57 18.23 33.81 % Of Sales - 7.25% 6.64% 6.89% 6.27% 4.14% 4.61% 4.68% 4.85% 4.09% 5.53% Employee Cost - 69.72 56.78 50.08 51.02 41.17 39.35 35.59 32.80 26.92 38.11 % Of Sales - 8.91% 8.01% 9.59% 9.81% 7.31% 9.55% 7.66% 7.05% 6.04% 6.23% Manufacturing Exp. - 42.85 37.87 28.08 25.80 16.28 14.89 13.29 12.14 10.35 37.94 % Of Sales - 5.47% 5.34% 5.38% 4.96% 2.89% 3.61% 2.86% 2.61% 2.32% 6.20% General & Admin Exp. - 22.45 20.68 12.48 15.32 14.93 8.05 8.69 8.45 9.00 10.51 % Of Sales - 2.87% 2.92% 2.39% 2.95% 2.65% 1.95% 1.87% 1.82% 2.02% 1.72% Selling & Distn. Exp. - 13.75 4.73 3.82 3.42 5.09 3.70 2.25 4.81 9.67 15.99 % Of Sales - 1.76% 0.67% 0.73% 0.66% 0.90% 0.90% 0.48% 1.03% 2.17% 2.61% Miscellaneous Exp. - 1.17 1.07 1.27 1.67 1.25 0.58 0.49 0.91 0.33 15.99 % Of Sales - 0.15% 0.15% 0.24% 0.32% 0.22% 0.14% 0.11% 0.20% 0.07% 0.13% EBITDA 172.38 139.98 116.98 54.73 114.77 121.14 80.03 90.14 93.34 75.14 89.21 EBITDA Margin 19.21% 17.88% 16.49% 10.48% 22.08% 21.51% 19.43% 19.39% 20.08% 16.87% 14.59% Other Income 7.19 6.22 4.46 4.91 5.20 3.45 5.11 3.40 2.39 1.45 3.61 Interest 22.86 18.54 23.60 21.97 19.16 11.19 12.32 11.92 15.48 15.82 17.11 Depreciation 38.43 34.34 31.52 32.13 32.15 22.28 22.07 19.27 19.90 19.18 19.43 PBT 118.29 93.32 66.33 5.55 68.65 91.12 50.76 62.35 60.35 41.58 56.27 Tax 30.97 24.94 16.91 1.47 0.62 30.16 18.07 20.90 19.89 5.97 14.63 Tax Rate 26.18% 26.73% 25.49% 26.49% 0.90% 33.10% 35.60% 33.52% 32.96% 14.36% 26.00% PAT 87.31 68.38 49.42 4.08 68.04 60.96 32.69 41.45 40.45 35.61 41.64 PAT before Minority Interest 87.31 68.38 49.42 4.08 68.04 60.96 32.69 41.45 40.45 35.61 41.64 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.73% 8.74% 6.97% 0.78% 13.09% 10.82% 7.94% 8.92% 8.70% 7.99% 6.81% PAT Growth 37.11% 38.37% 1,111.27% -94.00% 11.61% 86.48% -21.13% 2.47% 13.59% -14.48% EPS 9.32 7.30 5.27 0.44 7.26 6.51 3.49 4.42 4.32 3.80 4.44

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 897.13 782.75 709.26 522.05 519.87 563.18 411.95 464.91 464.93 445.49 611.53 Net Sales Growth 14.97% 10.36% 35.86% 0.42% -7.69% 36.71% -11.39% 0.00% 4.36% -27.15% Cost Of Goods Sold 512.49 437.06 424.26 335.80 275.45 340.00 246.36 292.71 289.90 295.85 385.15 Gross Profit 384.64 345.69 285.00 186.24 244.43 223.18 165.59 172.20 175.03 149.64 226.38 GP Margin 42.87% 44.16% 40.18% 35.67% 47.02% 39.63% 40.20% 37.04% 37.65% 33.59% 37.02% Total Expenditure 724.93 643.76 592.50 467.52 405.26 442.04 331.92 374.77 371.59 370.35 522.32 Power & Fuel Cost - 56.76 47.12 35.97 32.58 23.31 18.99 21.75 22.57 18.23 33.81 % Of Sales - 7.25% 6.64% 6.89% 6.27% 4.14% 4.61% 4.68% 4.85% 4.09% 5.53% Employee Cost - 69.72 56.78 50.08 51.02 41.17 39.35 35.59 32.80 26.92 38.11 % Of Sales - 8.91% 8.01% 9.59% 9.81% 7.31% 9.55% 7.66% 7.05% 6.04% 6.23% Manufacturing Exp. - 42.85 37.87 28.08 25.80 16.28 14.89 13.29 12.14 10.35 37.94 % Of Sales - 5.47% 5.34% 5.38% 4.96% 2.89% 3.61% 2.86% 2.61% 2.32% 6.20% General & Admin Exp. - 22.46 20.68 12.48 15.32 14.93 8.05 8.69 8.45 9.00 10.51 % Of Sales - 2.87% 2.92% 2.39% 2.95% 2.65% 1.95% 1.87% 1.82% 2.02% 1.72% Selling & Distn. Exp. - 13.75 4.73 3.82 3.42 5.09 3.70 2.25 4.81 9.67 15.99 % Of Sales - 1.76% 0.67% 0.73% 0.66% 0.90% 0.90% 0.48% 1.03% 2.17% 2.61% Miscellaneous Exp. - 1.17 1.07 1.27 1.67 1.25 0.58 0.49 0.91 0.33 15.99 % Of Sales - 0.15% 0.15% 0.24% 0.32% 0.22% 0.14% 0.11% 0.20% 0.07% 0.13% EBITDA 172.19 138.99 116.76 54.53 114.61 121.14 80.03 90.14 93.34 75.14 89.21 EBITDA Margin 19.19% 17.76% 16.46% 10.45% 22.05% 21.51% 19.43% 19.39% 20.08% 16.87% 14.59% Other Income 7.19 6.22 4.46 4.91 5.20 3.45 5.11 3.40 2.39 1.45 3.61 Interest 22.86 18.54 23.60 21.97 19.16 11.19 12.32 11.92 15.48 15.82 17.11 Depreciation 38.43 34.34 31.52 32.13 32.15 22.28 22.07 19.27 19.90 19.18 19.43 PBT 118.09 92.34 66.11 5.35 68.50 91.12 50.76 62.35 60.35 41.58 56.27 Tax 30.97 24.94 16.91 1.47 0.62 30.16 18.07 20.90 19.89 5.97 14.63 Tax Rate 26.23% 27.01% 25.58% 27.48% 0.91% 33.10% 35.60% 33.52% 32.96% 14.36% 26.00% PAT 87.11 67.40 49.20 3.88 67.88 60.96 32.69 41.45 40.45 35.61 41.64 PAT before Minority Interest 87.11 67.40 49.20 3.88 67.88 60.96 32.69 41.45 40.45 35.61 41.64 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 9.71% 8.61% 6.94% 0.74% 13.06% 10.82% 7.94% 8.92% 8.70% 7.99% 6.81% PAT Growth 37.48% 36.99% 1,168.04% -94.28% 11.35% 86.48% -21.13% 2.47% 13.59% -14.48% EPS 9.30 7.19 5.25 0.41 7.24 6.51 3.49 4.42 4.32 3.80 4.44

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 673.07 570.49 495.10 493.76 428.22 367.42 339.92 301.11 262.63 294.36 Share Capital 8.87 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 Total Reserves 648.33 533.45 486.63 485.30 419.76 358.96 331.46 292.64 254.17 285.90 Non-Current Liabilities 188.67 166.05 164.17 192.73 206.26 114.47 94.35 96.58 91.41 161.56 Secured Loans 138.16 120.89 119.93 148.30 146.21 67.02 61.01 70.20 73.02 109.58 Unsecured Loans 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 3.64 Long Term Provisions 1.21 1.16 1.40 1.57 1.84 1.73 1.52 2.18 1.35 3.43 Current Liabilities 344.50 346.72 254.97 211.48 211.43 154.21 156.05 134.29 156.00 200.43 Trade Payables 113.91 151.32 107.43 72.86 65.44 44.49 47.70 39.27 66.75 84.40 Other Current Liabilities 84.54 65.37 52.65 54.69 58.31 38.84 23.32 22.91 19.95 40.37 Short Term Borrowings 124.80 114.00 93.79 67.91 70.86 61.16 70.81 58.40 59.76 72.75 Short Term Provisions 21.24 16.03 1.10 16.02 16.82 9.72 14.22 13.71 9.54 2.90 Total Liabilities 1,206.24 1,083.26 914.24 897.97 845.91 636.10 590.32 531.98 510.04 656.35 Net Block 532.98 437.26 412.02 437.99 457.36 280.49 281.26 279.26 290.45 370.35 Gross Block 760.33 630.61 575.55 569.62 558.80 360.77 339.57 318.34 309.63 433.08 Accumulated Depreciation 227.35 193.35 163.53 131.63 101.44 80.29 58.31 39.08 19.18 62.73 Non Current Assets 631.64 534.36 503.54 505.92 520.58 408.32 369.23 350.66 343.68 408.79 Capital Work in Progress 34.67 30.27 33.19 11.00 6.74 42.12 18.30 8.20 7.76 12.80 Non Current Investment 45.11 45.10 45.10 45.00 45.00 45.00 45.00 45.00 36.98 21.27 Long Term Loans & Adv. 15.94 19.04 10.70 9.32 9.10 38.47 22.55 16.19 6.58 4.37 Other Non Current Assets 2.95 2.69 2.54 2.61 2.38 2.25 2.13 2.01 1.90 0.00 Current Assets 574.60 548.89 410.70 392.05 325.33 227.78 221.09 181.32 166.36 247.55 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 284.73 233.70 223.50 251.10 137.79 129.20 136.40 107.48 92.52 112.68 Sundry Debtors 203.23 236.23 148.35 48.52 105.68 48.77 26.02 24.15 21.32 61.09 Cash & Bank 41.58 36.20 7.47 46.66 40.51 9.65 14.88 12.71 12.37 15.08 Other Current Assets 45.05 6.77 6.00 6.39 41.35 40.15 43.79 36.98 40.15 58.70 Short Term Loans & Adv. 36.61 35.99 25.39 39.39 22.17 36.33 17.06 14.89 11.67 23.49 Net Current Assets 230.10 202.18 155.74 180.57 113.90 73.57 65.04 47.03 10.36 47.13 Total Assets 1,206.24 1,083.25 914.24 897.97 845.91 636.10 590.32 531.98 510.04 656.34

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 639.64 536.33 460.53 470.29 410.53 348.24 321.92 284.49 254.74 293.60 Share Capital 8.87 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 8.47 Total Reserves 614.90 499.29 452.06 461.82 402.06 339.77 313.45 276.02 246.28 285.14 Non-Current Liabilities 188.67 166.05 164.17 192.73 206.26 114.47 94.35 96.58 91.41 161.56 Secured Loans 138.16 120.89 119.93 148.30 146.21 67.02 61.01 70.20 73.02 109.58 Unsecured Loans 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20 3.64 Long Term Provisions 1.21 1.16 1.40 1.57 1.84 1.73 1.52 2.18 1.35 3.43 Current Liabilities 344.50 346.72 254.97 211.48 211.43 154.21 156.05 134.29 156.00 200.43 Trade Payables 113.92 151.32 107.43 72.86 65.44 44.49 47.70 39.27 66.75 84.40 Other Current Liabilities 84.54 65.37 52.65 54.69 58.31 38.84 23.32 22.91 19.95 40.37 Short Term Borrowings 124.80 114.00 93.79 67.91 70.86 61.16 70.81 58.40 59.76 72.75 Short Term Provisions 21.24 16.03 1.10 16.02 16.82 9.72 14.22 13.71 9.54 2.90 Total Liabilities 1,172.81 1,049.10 879.67 874.50 828.22 616.92 572.32 515.36 502.15 655.59 Net Block 532.98 437.26 412.02 437.99 457.36 280.49 281.26 279.26 290.45 370.35 Gross Block 760.33 630.61 575.55 569.62 558.80 360.77 339.57 318.34 309.63 500.81 Accumulated Depreciation 227.35 193.35 163.53 131.63 101.44 80.29 58.31 39.08 19.18 130.46 Non Current Assets 598.21 500.20 468.96 482.45 502.88 389.13 351.22 334.04 335.80 408.04 Capital Work in Progress 34.67 30.27 33.19 11.00 6.74 42.12 18.30 8.20 7.76 12.80 Non Current Investment 11.68 10.94 10.52 21.53 27.30 25.81 26.99 28.38 29.10 20.51 Long Term Loans & Adv. 15.94 19.04 10.70 9.32 9.10 38.47 22.55 16.19 6.58 4.37 Other Non Current Assets 2.95 2.69 2.54 2.61 2.38 2.25 2.13 2.01 1.90 0.00 Current Assets 574.60 548.89 410.70 392.05 325.33 227.78 221.09 181.32 166.36 247.55 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 284.73 233.70 223.50 251.10 137.79 129.20 136.40 107.48 92.52 112.68 Sundry Debtors 203.23 236.23 148.35 48.52 105.68 48.77 26.02 24.15 21.32 61.09 Cash & Bank 41.59 36.20 7.47 46.66 40.51 9.65 14.88 12.71 12.37 15.08 Other Current Assets 45.05 6.77 6.00 6.39 41.35 40.15 43.79 36.98 40.15 58.70 Short Term Loans & Adv. 36.61 35.99 25.39 39.39 22.17 36.33 17.06 14.89 11.67 23.49 Net Current Assets 230.10 202.18 155.74 180.57 113.90 73.57 65.04 47.03 10.36 47.13 Total Assets 1,172.81 1,049.09 879.66 874.50 828.21 616.91 572.31 515.36 502.16 655.59

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 81.71 50.12 22.45 45.06 90.45 39.71 49.76 31.81 73.47 61.22 PBT 93.32 66.33 5.55 68.65 91.12 50.76 62.35 60.35 41.58 56.27 Adjustment 51.31 53.74 52.79 49.70 27.76 28.66 26.81 31.08 31.58 28.14 Changes in Working Capital -43.08 -54.55 -31.29 -58.38 -12.38 -27.60 -26.02 -48.48 9.40 -1.17 Cash after chg. in Working capital 101.55 65.52 27.05 59.98 106.50 51.82 63.14 42.95 82.56 83.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -19.83 -15.40 -4.60 -14.92 -16.05 -12.10 -13.38 -11.14 -9.09 -22.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -123.44 -52.07 -29.76 -27.15 -151.59 -42.56 -34.67 -16.58 -38.96 -96.72 Net Fixed Assets -134.12 -52.14 -28.12 -15.08 -162.65 -45.02 -31.33 -9.15 128.49 -28.01 Net Investments -0.01 0.00 -0.10 0.00 0.00 0.00 0.00 -8.02 -15.71 -8.04 Others 10.69 0.07 -1.54 -12.07 11.06 2.46 -3.34 0.59 -151.74 -60.67 Cash from Financing Activity 47.08 30.68 -31.97 -11.75 92.02 -2.40 -12.92 -14.89 -33.19 44.34 Net Cash Inflow / Outflow 5.35 28.73 -39.27 6.16 30.88 -5.25 2.17 0.35 1.32 8.84 Opening Cash & Equivalents 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25 2.41 Closing Cash & Equivalent 41.39 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 81.71 50.12 22.45 45.06 90.45 39.71 49.76 31.81 73.47 61.22 PBT 92.34 66.11 5.35 68.50 91.12 50.76 62.35 60.35 41.58 56.27 Adjustment 52.28 53.97 52.99 49.86 27.76 28.66 26.81 31.08 31.58 28.14 Changes in Working Capital -43.08 -54.55 -31.29 -58.38 -12.38 -27.60 -26.02 -48.48 9.40 -1.17 Cash after chg. in Working capital 101.54 65.52 27.05 59.98 106.50 51.82 63.14 42.95 82.56 83.24 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -19.83 -15.40 -4.60 -14.92 -16.05 -12.10 -13.38 -11.14 -9.09 -22.02 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -123.43 -52.07 -29.76 -27.15 -151.59 -42.56 -34.67 -16.58 -38.96 -96.72 Net Fixed Assets -134.12 -52.14 -28.12 -15.08 -162.65 -45.02 -31.33 -9.15 128.49 Net Investments -0.01 0.00 -0.10 0.00 0.00 0.00 0.00 -8.02 -15.71 Others 10.70 0.07 -1.54 -12.07 11.06 2.46 -3.34 0.59 -151.74 Cash from Financing Activity 47.08 30.68 -31.97 -11.75 92.02 -2.40 -12.92 -14.89 -33.19 44.34 Net Cash Inflow / Outflow 5.36 28.73 -39.27 6.16 30.88 -5.25 2.17 0.35 1.32 8.84 Opening Cash & Equivalents 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25 2.41 Closing Cash & Equivalent 41.40 36.04 7.31 46.58 40.42 9.54 14.80 12.63 12.29 11.25

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 74.13 64.02 58.49 58.33 50.59 43.40 40.16 35.57 31.02 34.77 ROA 5.97% 4.95% 0.45% 7.80% 8.23% 5.33% 7.39% 7.76% 6.11% 6.96% ROE 11.41% 9.53% 0.83% 14.76% 15.32% 9.24% 12.93% 14.35% 12.79% 15.17% ROCE 12.20% 11.25% 3.67% 12.26% 17.07% 12.57% 15.96% 17.66% 12.61% 15.95% Fixed Asset Turnover 1.22 1.27 0.97 0.98 1.32 1.29 1.53 1.59 1.22 1.53 Receivable days 94.73 91.77 65.01 50.80 46.40 30.27 18.23 16.66 33.12 34.86 Inventory Days 111.76 109.10 156.71 128.12 80.21 107.49 88.61 73.28 82.47 57.59 Payable days 111.00 111.36 98.04 91.68 59.01 46.62 40.24 46.81 71.90 49.65 Cash Conversion Cycle 95.49 89.51 123.68 87.24 67.61 91.14 66.60 43.12 43.69 42.80 Total Debt/Equity 0.47 0.52 0.51 0.53 0.59 0.41 0.42 0.49 0.57 0.69 Interest Cover 6.03 3.81 1.25 4.58 9.14 5.12 6.23 4.90 3.63 4.29

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 70.36 59.98 54.40 55.56 48.50 41.14 38.03 33.61 30.09 34.68 ROA 6.07% 5.10% 0.44% 7.97% 8.44% 5.50% 7.62% 7.95% 6.15% 8.46% ROE 11.91% 10.16% 0.83% 15.41% 16.07% 9.76% 13.67% 15.00% 12.99% 17.57% ROCE 12.55% 11.73% 3.79% 12.60% 17.62% 13.06% 16.57% 18.17% 12.73% 19.54% Fixed Asset Turnover 1.22 1.27 0.97 0.98 1.32 1.29 1.53 1.59 1.12 2.11 Receivable days 94.73 91.77 65.01 50.80 46.40 30.27 18.23 16.66 33.12 35.09 Inventory Days 111.76 109.10 156.71 128.12 80.21 107.49 88.61 73.28 82.47 47.02 Payable days 110.75 111.30 97.98 91.63 59.01 46.62 40.24 46.81 71.90 36.96 Cash Conversion Cycle 95.74 89.57 123.74 87.30 67.61 91.14 66.60 43.12 43.69 45.14 Total Debt/Equity 0.50 0.55 0.55 0.55 0.61 0.44 0.45 0.51 0.59 0.70 Interest Cover 5.98 3.80 1.24 4.57 9.14 5.12 6.23 4.90 3.63 4.29

Top Investors:

quant mutual fund - quant small cap fund

venkata subbaraju penmatsa (huf)

sudeepthi gopineedi

venkata praveen talluri

aniruddh mundra

Annual Reports:

News Update:

USFDA completes inspection at SMS Pharmaceuticals’ API manufacturing facility at Visakhapatnam
13th Dec 2025, 12:29 PM

The inspection concluded with one minor observation in Form 483
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback